Catalyst Event
Alphabet Inc (GOOGL) · Earnings Release
From KEDI U.S. Medical AI Index (KUSMAI)
4/23/2026, 12:00:00 AM
Alphabet's Q1 2026 earnings release on April 23, 2026, with low importance estimated as no market reaction has occurred yet, expected.
Korean Translation
알파벳의 2026년 4월 23일 2026년 1분기 실적 발표가 아직 시장 반응이 없어 낮은 중요도로 예상되며 예정됨.
Related Recent Events
Recursion Pharmaceauticals Inc (RXRX) · Earnings Release
First quarter 2026 earnings release is scheduled for May 11, 2026, with analysts forecasting an EPS of approximately -$0.25. This event is critical for monitoring cash burn, justifying a medium importance estimate (expected 5-10% impact), forecasted
5/11/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
As quarterly earnings are key volatility events for growth-stage AI companies, Tempus AI's Q1 2026 earnings release on May 5, 2026, is scheduled
5/5/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release is scheduled; medium importance is estimated based on expected >=5% price impact.
4/30/2026, 12:00:00 AM
Intuitive Surgical Inc (ISRG) · Earnings Release
Q1 2026 earnings release and conference call for 2026-04-21 scheduled. Low importance is estimated due to the routine nature of the announcement scheduled.
4/21/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
FDA decision on oral weight-loss drug orforglipron is expected; high importance is estimated due to potential for >=10% price impact.
4/10/2026, 12:00:00 AM
Recursion Pharmaceauticals Inc (RXRX) · Other
Vicki Goodman, M.D., with over 20 years of oncology drug development experience, is scheduled to become the new Chief Medical Officer, effective April 6, 2026. This appointment is a key milestone for clinical development, justifying a medium importance estimate (expected 5-10% impact), scheduled
4/6/2026, 12:00:00 AM